Edgewise Therapeutics Inc
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 100.0% | – | – | – | 100.0% | – | – | – | – | – | – | – | |
| – | 23.7% | – | – | – | 50.0% | – | – | – | – | – | – | – | |
| – | 76.3% | – | – | – | 50.0% | – | – | – | – | – | – | – | |
| – | 1,229.3% | – | – | – | 1,717.2% | – | – | – | – | – | – | – | |
| – | 274.3% | – | – | – | 433.0% | – | – | – | – | – | – | – | |
| – | 1,503.6% | – | – | – | 2,150.1% | – | – | – | – | – | – | – | |
| – | -1,503.6% | – | – | – | -2,150.1% | – | – | – | – | – | – | – | |
| – | 138.0% | – | – | – | – | – | – | – | – | – | – | – | |
| – | -1,338.5% | – | – | – | -1,872.6% | – | – | – | – | – | – | – | |
| – | 160.0% | – | – | – | -22.7% | – | – | – | – | – | – | – | |
| – | -1,338.5% | – | – | – | -1,872.6% | – | – | – | – | – | – | – | |
| – | -1,314.8% | – | – | – | -1,842.9% | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.